Title of article :
Association of Acute Lymphoblastic Leukemia and MDR1 Gene Polymorphism in an Ethnic Iranian Population
Author/Authors :
Miladpour, Behnoush mashhad university of medical sciences - Biotechnology Research Center, مشهد, ايران , Nejat Shokouhi, Amireh mashhad university of medical sciences - Department of Clinical Biochemistry, مشهد, ايران , Shirdel, Abbas mashhad university of medical sciences - Department of Internal Medicine, مشهد, ايران , Entezari Heravi, Reza mashhad university of medical sciences - Biotechnology Research Center, مشهد, ايران , Banihashem, Abdollah mashhad university of medical sciences - Department of Internal Medicine, مشهد, ايران , Habibollah, Esmaeili mashhad university of medical sciences - Department of Medical Statistics, مشهد, ايران , Khedri, Azam mashhad university of medical sciences - Biotechnology Research Center, مشهد, ايران , Behravan, Javad mashhad university of medical sciences - Biotechnology Research Center, مشهد, ايران
From page :
63
To page :
67
Abstract :
Background: The frequency of the multi-drug resistance 1 (MDR1) gene C3435T polymorphism differs in various ethnical populations such as Asian, African, and Caucasians populations. A silent C3435T polymorphism in exon 26 of MDR1 has been reported to be associated with a decreased expression of P-gp in TT genotypes carriers compared with CC genotypes carriers. Materials and Methods: To evaluate the association between MDR1 gene C3435T polymorphism and acute lymphocyte leukemia (ALL), 126 ALL patients (72 males and 54 females) with a mean age of 11.42 ± 6.55 and 139 healthy controls (79 males and 60 females) with a mean age of 12.15 ± 7.5 who were referred to Dr. Sheykh hospital, Mashhad, Iran, between 2005-2007 were enrolled in our study and their C3435T MDR1 polymorphism was investigated using PCR-RFLP. Results: The mutant homozygous TT and TC genotypes were found to be associated with the incidence of ALL (p 0.05). There was no significant difference for T allele frequency between ALL patients and healthy controls (OR=1.08, 95% CI; 0.84-1.66, p=0.33). Conclusion: TT genotypes carriers are at higher risk of developing ALL than carriers of other genotypes.
Keywords :
p , glycoprotein , multi , drug resistance , acute lymphoblastic leukemia , polymorphism
Journal title :
Iranian Journal of Blood and Cancer (IJBC)
Journal title :
Iranian Journal of Blood and Cancer (IJBC)
Record number :
2549497
Link To Document :
بازگشت